Cargando…
Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
Autores principales: | Yonker, Lael M., Badaki-Makun, Oluwakemi, Arya, Puneeta, Boribong, Brittany P., Moraru, Gabriela, Fenner, Brittany, Rincon, Jaimar, Hopke, Alex, Rogers, Brent, Hinson, Jeremiah, Fasano, Alessio, Lee, Lilly, Kehoe, Sarah M., Larson, Shawn D., Chavez, Hector, Levin, Scott, Moldawer, Lyle L., Irimia, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260969/ https://www.ncbi.nlm.nih.gov/pubmed/35799137 http://dx.doi.org/10.1186/s12879-022-07563-4 |
Ejemplares similares
-
Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
por: Yonker, Lael M., et al.
Publicado: (2022) -
Monocyte anisocytosis corresponds with increasing severity of COVID-19 in children
por: Kane, Abigail S., et al.
Publicado: (2023) -
The Heart of the Problem in Multisystem Inflammatory Syndrome in Children
por: Boribong, Brittany P., et al.
Publicado: (2021) -
Zonulin Antagonist, Larazotide (AT1001), As an Adjuvant Treatment for Multisystem Inflammatory Syndrome in Children: A Case Series
por: Yonker, Lael M., et al.
Publicado: (2022) -
Heterogeneity in the evaluation of suspected MIS-C: a cross-sectional vignette-based survey
por: Rosu, Claudia A., et al.
Publicado: (2022)